Afficher la notice abrégée

Shaping the future of pharmacoepidemiology in France: recommendations from the SFPT Pharmacoepidemiology Working Group

dc.rights.licenseopenen_US
hal.structure.identifierInstitut de Neurosciences des Systèmes [INS]
dc.contributor.authorSOEIRO, Thomas
hal.structure.identifierUniversité de Poitiers = University of Poitiers [UP]
dc.contributor.authorALLOUCHERY, Marion
ORCID: 0000-0002-8261-9549
IDREF: 193082543
hal.structure.identifierCentre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
dc.contributor.authorBÉNÉ, Johana
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBEZIN, Julien
hal.structure.identifierUniversité de Caen Normandie [UNICAEN]
hal.structure.identifierUnité de recherche interdisciplinaire pour la prévention et le traitement des cancers [ANTICIPE]
dc.contributor.authorDOLLADILLE, Charles
hal.structure.identifierUniversité de Montpellier [UM]
hal.structure.identifierInstitut Desbrest de santé publique [IDESP]
dc.contributor.authorFAILLIE, Jean-Luc
hal.structure.identifierCentre de recherche en épidémiologie et santé des populations [CESP]
dc.contributor.authorGRIMALDI, Lamiae
hal.structure.identifierHôpital Robert Debré
hal.structure.identifierCentre d'Investigation Clinique 1426 [CIC 1426]
dc.contributor.authorKAGUELIDOU, Florentia
hal.structure.identifierUniversité Grenoble Alpes [UGA]
hal.structure.identifierHypoxie et PhysioPathologie [HP2]
dc.contributor.authorKHOURI, Charles
hal.structure.identifierCentre Hospitalier Universitaire de Toulouse [CHU Toulouse]
hal.structure.identifierCentre d'investigation clinique de Toulouse [CIC 1436]
dc.contributor.authorLAFAURIE, Margaux
hal.structure.identifierUniversité de Tours [UT]
hal.structure.identifierMembrane Signalling and Inflammation in reperfusion Injuries [ISCHEMIA ]
dc.contributor.authorLARGEAU, Bérenger
hal.structure.identifierCentre Hospitalier Universitaire de Toulouse [CHU Toulouse]
hal.structure.identifierCentre d'investigation clinique de Toulouse [CIC 1436]
dc.contributor.authorMONTASTRUC, François
hal.structure.identifierCentre de recherche en épidémiologie et santé des populations [CESP]
dc.contributor.authorMORIN, Lucas
hal.structure.identifierCentre Hospitalier Universitaire [Rennes]
hal.structure.identifierInstitut de recherche en santé, environnement et travail [Irset]
dc.contributor.authorSCAILTEUX, Lucie-Marie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPARIENTE, Antoine
dc.date.accessioned2025-01-30T08:49:39Z
dc.date.available2025-01-30T08:49:39Z
dc.date.issued2024-12-14
dc.identifier.issn0040-5957en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/204656
dc.description.abstractEnThe drug authorization process is shifting towards a policy aimed at shortening time-to-market. While this policy facilitates early access to new treatments, it can also result in potentially insufficient knowledge of both efficacy and safety at the time of marketing. The latter is particularly true for long-term outcomes or in specific populations (e.g., children and the elderly). Yet, French pharmacoepidemiology is currently not designed to address these challenges, despite recognized expertise. In this context, we aim: (i) to define a strategy for strengthening pharmacoepidemiology in France; and (ii) to identify the associated human, technical, and financial requirements to ensure its success. In this paper, we present the French Pharmacoepidemiology Initiative (https://frenchpharmacoepi.org/), i.e. a network of independent academic teams to complement existing institutions. It will provide coordinated expertise and a workforce to meet national and regional needs for pharmacoepidemiological monitoring and drug-related decision-making. Leveraging the existing expertise of university hospital pharmacoepidemiology units would enable rapid operational deployment to inform the decisions and policies of national regulatory agencies.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enClaims databases
dc.subject.enHospital data warehouses
dc.subject.enPharmacoepidemiology
dc.subject.enPrescription drugs
dc.subject.enReal-world data
dc.title.enShaping the future of pharmacoepidemiology in France: recommendations from the SFPT Pharmacoepidemiology Working Group
dc.title.alternativeTherapieen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.therap.2024.12.005en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39706774en_US
bordeaux.journalTherapiesen_US
bordeaux.page00213-0en_US
bordeaux.volumeS0040-5957en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue24en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamAHEAD_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcehal
hal.identifierhal-04870620
hal.version1
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Therapies&rft.date=2024-12-14&rft.volume=S0040-5957&rft.issue=24&rft.spage=00213-0&rft.epage=00213-0&rft.eissn=0040-5957&rft.issn=0040-5957&rft.au=SOEIRO,%20Thomas&ALLOUCHERY,%20Marion&B%C3%89N%C3%89,%20Johana&BEZIN,%20Julien&DOLLADILLE,%20Charles&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Nom:
BPH_Therapie_2024_Soeiro.pdf
Taille:
710.9Ko
Format:
PDF
Voir/Ouvrir
Thumbnail
Nom:
license_rdf
Taille:
914octets
Format:
application/rdf+xml
Voir/Ouvrir

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée